⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14240697 | 0.77 | ALDH1A1 (0.38) | — | |
| SCHEMBL60367 | 0.74 | — | — | |
| Phosphoric Acid SCHEMBL27520956 | 0.72 | ALDH1A1 (0.33) | — | |
| SCHEMBL19664757 | 0.72 | — | — | |
| SCHEMBL10771605 | 0.72 | — | — | |
| SCHEMBL23530995 | 0.72 | — | — | |
| SCHEMBL14602490 | 0.72 | — | — | |
| SCHEMBL25238619 | 0.72 | — | — | |
| SCHEMBL10446072 | 0.72 | — | — | |
| SCHEMBL23094106 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107365975-A | Delivery container with flow distributor | 弗萨姆材料美国有限责任公司 | 2017-11-21 | — | — | CN | claimed |
| CN-106148914-A | For the container of precursor in depositing operation | 气体产品与化学公司 | 2016-11-23 | — | — | CN | claimed |
| CN-105518826-A | Surface treatment for CCTBA-based CVD cobalt nucleation on dielectric substrates | APPLIED MATERIALS INC | 2016-04-20 | — | — | CN | claimed |
| CN-116669737-A | Antagonists of muscarinic acetylcholine receptor M4 | 范德堡大学 | 2023-08-29 | — | — | CN | disclosed |
| WO-2021143511-A1 | N, O TYPE MULTIDENTATE FUNCTIONAL MONOMER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN ION IMPRINTING MATERIAL | 武汉赛沣瑞技术有限公司 | 2021-07-22 | — | — | WO | disclosed |
| CN-107889486-B | Pyridin-2-ylpyridin/compounds and methods of use thereof | 日本曹达株式会社 | 2021-07-09 | — | — | CN | disclosed |
| US-10654818-B2 | Furane derivatives as inhibitors of ATAD2 | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2020-05-19 | — | — | US | disclosed |
| CN-107827956-B | Synthesis method of active cyclic octapeptide reniohalistatin E and analogues thereof | 暨南大学 | 2020-05-08 | — | — | CN | disclosed |
| CN-107827956-B | Synthesis method of active cyclic octapeptide reniohalistatin E and analogues thereof | 暨南大学 | 2020-05-08 | — | — | CN | disclosed |
| US-10618882-B2 | Pyridine-2-yl pyridinium compound and method of using same | NIPPON SODA CO., LTD. (JP) | 2020-04-14 | — | — | US | disclosed |
| EP-3383865-B1 | FURANE DERIVATIVES AS INHIBITORS OF ATAD2 | Bayer Pharma AG (DE) | 2020-01-29 | — | — | EP | disclosed |
| EP-1515724-A1 | MITOTIC KINESIN INHIBITORS | Merck & Co., Inc. (US) | 2005-03-23 | — | — | EP | disclosed |
| WO-2004111193-A2 | PRODRUGS OF MITOTIC KINESIN INHIBITORS | MERCK & CO., INC. (US) | 2004-12-23 | — | — | WO | disclosed |
| WO-2004087050-A2 | MITOTIC KINESIN INHIBITORS | MERCK & CO., INC. (US) | 2004-10-14 | — | — | WO | disclosed |
| US-20040152724-A1 | Azabicyclic compounds are central nervous system active agents | ABBVIE INC. | 2004-08-05 | — | — | US | disclosed |
| US-20040044029-A1 | Azabicyclic compounds are central nervous system active agents | ABBOTT LABORATORIES | 2004-03-04 | — | — | US | disclosed |
| WO-2004016604-A2 | AZABICYCLIC COMPOUNDS ARE CENTRAL NERVOUS SYSTEM ACTIVE AGENTS | ABBOTT LABORATORIES (US) | 2004-02-26 | — | — | WO | disclosed |
| WO-2003105855-A1 | MITOTIC KINESIN INHIBITORS | MERCK & CO., INC. (US) | 2003-12-24 | — | — | WO | disclosed |
| WO-2003106417-A1 | MITOTIC KINESIN INHIBITORS | MERCK & CO., INC. (US) | 2003-12-24 | — | — | WO | disclosed |
| CN-1114714-A | Reducing exhaust emissions from otto-cycle engines | ETHYL CORP (US) | 1996-01-10 | — | — | CN | disclosed |